Literature DB >> 2203854

Optimization of detection of bacterial endotoxin in plasma with the Limulus test.

R I Roth1, F C Levin, J Levin.   

Abstract

Detection and quantification of bacterial endotoxin in plasma by the Limulus amebocyte lysate test (or other assays for endotoxins) is hindered by the presence of inhibitors. Treatment of plasma to overcome inhibitory activities is required before plasma can be successfully assayed for endotoxin. We have conducted an investigation comparing the three most commonly used procedures (dilution-heating, trifluoroacetic acid oxidation, and chloroform extraction) for treatment of plasma before its assay for endotoxin with the chromogenic Limulus test. Initially, conditions were optimized for treatment of plasma by each of these methods. Subsequently, a direct comparison of the three plasma treatment procedures was performed with plasma spiked with known concentrations of endotoxin. The optimized dilution-heating procedure resulted in the most sensitive detection of endotoxin, with sensitivity approximately 10 times greater than the optimized trifluoroacetic acid oxidation procedure and approximately 100 times greater than treatment of plasma by chloroform extraction. Maximal detection of low concentrations of endotoxin by the chromogenic Limulus test was obtained by dilution of plasma fourfold with 0.15 mol/L NaCl followed by heating at 60 degrees C for 30 minutes. This procedure was simple, rapid, and did not involve addition of any reagents to plasma that could potentially add contaminating endotoxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203854

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Specialization of mucosal immunoglobulins in pathogen control and microbiota homeostasis occurred early in vertebrate evolution.

Authors:  Zhen Xu; Fumio Takizawa; Elisa Casadei; Yasuhiro Shibasaki; Yang Ding; Thomas J C Sauters; Yongyao Yu; Irene Salinas; J Oriol Sunyer
Journal:  Sci Immunol       Date:  2020-02-07

2.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

3.  Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis.

Authors:  R Francés; J M González-Navajas; P Zapater; C Muñoz; R Caño; S Pascual; F Santana; D Márquez; M Pérez-Mateo; J Such
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

4.  Lipopolysaccharide-binding proteins of Limulus amebocyte lysate.

Authors:  R I Roth; P S Tobias
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

5.  Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.

Authors:  J C Hurley
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

Review 6.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

7.  Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation.

Authors:  Z Y Huang; T Stabler; F X Pei; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2016-05-20       Impact factor: 6.576

8.  Metabolic Endotoxemia, Feeding Studies and the Use of the Limulus Amebocyte (LAL) Assay; Is It Fit for Purpose?

Authors:  Karma Pearce; Dianne Estanislao; Sinan Fareed; Kelton Tremellen
Journal:  Diagnostics (Basel)       Date:  2020-06-24

9.  An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test.

Authors:  Stephan Harm; Claudia Schildböck; Karin Strobl; Jens Hartmann
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

10.  Plasma Endotoxin Levels Are Not Increased in Schistosoma mansoni-Infected Women without Signs or Symptoms of Hepatosplenic Disease.

Authors:  Katherine M Klemperer; Mary Juliet Reust; Myung Hee Lee; Paul L A M Corstjens; Govert J van Dam; Humphrey D Mazigo; Kathryn M Dupnik; Jennifer A Downs
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.